Andrew Bellinger

Andrew Bellinger is the Chief Scientific Officer & Chief Medical Officer at Verve Therapeutics. Andrew has also Co-Founded Lyndra where they led R&D. Andrew Bellinger has also been a Research Affiliate, Langer Lab at MIT, a Chief Medical Advisor at BetterFit Technologies, an Attending Cardiologist at Brigham and Women's Hospital, a Fellow in Cardiovascular Medicine, and a Clinical Fellow in Medicine, all while being a Resident Physician at UCSF Medical Center.

Andrew Bellinger completed their undergraduate studies at Princeton University, where they earned an A.B. in physics. Andrew then pursued a Master of Science in applied mathematics at New York University. After completing their MS, they enrolled at Columbia University to earn their Doctor of Medicine (MD) through the Vagelos College of Physicians and Surgeons. Andrew also earned a Doctor of Philosophy (PhD) in biochemistry, biophysics, and molecular biology from Columbia University.

Sara Garcia - Associate Principal Scientist, Computational Biology, Ivan Ivanov - Scientist II, Editor Development, and Sagar Mudshinge - Scientist, Discovery Chemistry report to Andrew Bellinger. They are on a team with Seka Lazare - Associate Director, Next Generation Sequencing, Jeffrey Meltzer - VP, Quality, and Victoria Bartlett - VP, Program & Alliance Management. Andrew Bellinger reports to Sekar Kathiresan, Co-Founder & CEO.